Owen O'Connor, MD, PhD
Practice location
| Gender | Male |
|---|---|
| Board certification |
|
| Medical School | University of Medicine and Denistry of New Jersey |
| Internship | New York Hospital Presbyterian-Cornell Medical Ctr |
| Residency | New York Hospital Presbyterian-Cornell Medical Ctr |
| Fellowship | Memorial Sloan-Kettering Cancer Center |
| Group | White Plains Hospital Physician Associates |
| Accepted insurance | View accepted health insurance plans |
About
Dr. Owen A. O'Connor is internationally renowned for his expertise on the diagnosis and treatment of all forms of lymphoma, with over 25 years of experience in academic medicine. He has invented and pioneered the development of several first in class drugs for the treatment of lymphoma, including one he co-invented for T-cell lymphoma which has now been approved in over 35 countries around the world. He has held several prestigious leadership positions at the major cancer centers in New York City, including Memorial Sloan Kettering Cancer Center, New York University Medical Center, and Cornell and Columbia University Medical Centers.
After earning his Medical Degree from the University of Medicine & Dentistry of New Jersey, Dr. O'Connor went on to undertake his Internship and Residency in Internal Medicine at the New York Hospital/Cornell University Medical Center. He then completed two fellowships, including one in Medical Oncology in the Department of Medicine, under the Clinical Investigator Program (in the laboratory of Dr. Joseph R. Bertino), at Memorial Sloan Kettering Cancer Center, and a second in Clinical Pharmacology in the Division of Pharmacology in the Department of Medicine, New York Hospital – Cornell University Medical School. He was appointed Chief Medical Oncology Fellow, Department of Medicine, Memorial Sloan Kettering Cancer Center.
Dr. O'Connor has published over 200 articles in peer reviewed journals, books and book chapters and reviews on the management of lymphoma. He is the Editor of the first textbook on the Peripheral T-Cell Lymphoma and is now editing a new series of books for Wiley Sciences on Precision Cancer Therapies. He was a member of the Scientific Advisory Board for the Lymphoma Research Foundation, and the Leukemia Lymphoma Society, and has received countless awards for his research, including being named to Americas Top Cancer Doctors, being named among the Top 50 Irish-Americans in Science and Medicine by the Irish government, and being inducted into the New Jersey Inventors Hall of Fame. He is also a recipient of the American Cancer Society Research Professorship, the most prestigious honor bestowed by the Society.
Medical Expertise
- American Cancer Society Research Professor, Division of Hematology and Oncology and Director, Program for T-Cell Lymphoma Research, E. Couric Cancer Center, University of Virginia Cancer Center
- Professor, Department of Microbiology, Immunology, and Cancer Biology, University of Virginia
- Chief Scientific Officer, TG Therapeutics